Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Summary: β-adrenergic receptor activation promotes brown adipose tissue (BAT) β-oxidation and thermogenesis by burning fatty acids during uncoupling respiration. Oleoylethanolamide (OEA) can inhibit feeding and stimulate lipolysis by activating the peroxisome proliferator-activating receptor-α (PPARα) in the white adipose tissue (WAT). Here we explore whether PPARα activation potentiates the effect of β3-adrenergic stimulation on energy balance mediated by the respective agonists OEA and CL316243. The effect of this pharmacological association was monitored on feeding, thermogenesis, β-oxidation and lipid/cholesterol metabolism in epididymal (e)WAT. CL316243 (1 mg/kg) and OEA (5 mg/kg) co-administration over 6 days enhanced the reduction of food intake and body weight gain, increased the energy expenditure and reduced the respiratory quotient (VCO2/VO2). This negative energy balance agreed with decreased fat mass and increased BAT weight and temperature, as well as lowered plasma levels of triglycerides, cholesterol, NEFAs and the adipokines leptin and TNF-α. Regarding eWAT, CL316243 and OEA treatment elevated the thermogenic factors PPARα and UCP1, reduced p38-MAPK phosphorylation, and promoted brown-like features in the white adipocytes, as the mitochondrial (Cox4i1, Cox4i2) and BAT (Fgf21, Prdm16) genes were over-expressed in eWAT. The enhancement of the fatty acid β-oxidation factors Cpt1b and Acox1 in eWAT was accompanied with an up-regulation of de novo lipogenesis and a reduction of the unsaturated fatty acid synthesis enzyme Scd1. We propose that the combination of β-adrenergic and PPARα receptor agonists promote therapeutic adipocyte remodelling in eWAT that confer a potential clinical utility for the treatment of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · cited 2×
“Given that BAT has traditionally been considered to show discrete physiological relevance in humans (Cannon and Nedergaard, 2004; Virtanen et al., 2009), it is reasonable to anticipate that the effect of β3-adrenergic agonists on energy expenditure in humans will be less efficient than might be…”
BackgroundPRDM16 controls a brown fat/skeletal muscle switch
Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., Scimè, A., Devarakonda, S., Conroe, H. M., Erdjument-Bromage, H., et al. (2008) · Nature · doi:10.1038/nature07182 · Cited by 2,347 · cited 2×
“…16 (PRDM16), fibroblast growth factor (FGF)-21, PPARγ coactivator 1α (PGC-1α) and prostaglandins, have been proposed to induce a BAT-specific gene expression profile in response to adrenergic stimulation (Seale et al., 2007; Seale et al., 2008; Seale et al., 2011; Vegiopoulos et al., 2010).”
BackgroundFGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Towards a molecular understanding of adaptive thermogenesis
Lowell, B. B., & Spiegelman, B. M. (2000) · Nature · doi:10.1038/35007527 · Cited by 1,630 · cited 4×
“, 2002), whereas β3adrenergic agonists elicit potent effects on energy homeostasis by suppressing food intake, and promoting body fat loss, lipid oxidation, oxygen consumption and mitochondrial biogenesis, as well as improving insulin sensitivity and glucose tolerance (Arch and Wilson, 1996; Granneman et al., 2005; Lo…”
BackgroundInfluentialBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495 · cited 1×
“…by the β3-adrenergic receptor agonist CL316243 (Li et al., 2005) and is a critical regulator of thermogenic key components, including PRDM16, FGF21, PGC-1α and UCP1, in BAT (Badman et al., 2007; Chartoumpekis et al., 2011; Hondares et al., 2011a; Hondares et al., 2011b; Villarroya et al., 2007).”
BackgroundFeldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Previous studies reported that leptin secretion is positively correlated with adiposity (Skurk et al., 2007), and that TNF-α action is implicated in inflammatory response and insulin resistance, at least in obesity (Zhang et al., 2002).”
BackgroundPetrovic, N., Walden, T. B., Shabalina, I. G., Timmons, J. A., Cannon, B., & Nedergaard, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053942 · Cited by 1,263 · cited 1×
“…contrast, cold exposure or pharmacological activation of β3adrenergic receptors induces the appearance of brown fat-like (‘brite’) adipocytes in WAT (Cousin et al., 1992; Ishibashi and Seale, 2010; Petrovic et al., 2010), suggesting a mechanism for adipocyte progenitors to promote WAT remodelling.”
BackgroundTranscriptional Control of Brown Fat Determination by PRDM16
Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L. M., Uldry, M., Tavernier, G., Langin, D., & Spiegelman, B. M. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.001 · Cited by 1,174 · cited 5×
“…16 (PRDM16), fibroblast growth factor (FGF)-21, PPARγ coactivator 1α (PGC-1α) and prostaglandins, have been proposed to induce a BAT-specific gene expression profile in response to adrenergic stimulation (Seale et al., 2007; Seale et al., 2008; Seale et al., 2011; Vegiopoulos et al., 2010).”
BackgroundInfluentialFibroblast Growth Factor 21 Corrects Obesity in Mice
Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen, Y., Moller, D. E., & Kharitonenkov, A. (2008) · Endocrinology · doi:10.1210/en.2008-0816 · Cited by 1,031
Cited by
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.211 · Cited by 367
Decara, J., Arrabal, S., Beiroa, D., Rivera, P., Vargas, A., Serrano, A., Pavón, F. J., Ballesteros, J., Dieguez, C., Nogueiras, R., et al. (2016) · BioFactors · doi:10.1002/biof.1295 · Cited by 42
Self-citationPazos, P., Lima, L., Tovar, S., González-Touceda, D., Diéguez, C., & García, M. C. (2015) · Scientific Reports · doi:10.1038/srep17977 · Cited by 33
Self-citation
Metadata
- Authors
- Suárez, J., Rivera, P., Arrabal, S., Crespillo, A., Serrano, A., Baixeras, E., Pavón, F. J., Cifuentes, M., Nogueiras, R., Ballesteros, J., Dieguez, C., & Rodríguez de Fonseca, F.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2013-01-01
- Volume
- 7
- Issue
- 1
- Pages
- 129-41
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2146119241
- Cited by
- 60
- References
- 17
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. https://app.cochat.ai/papers/10.1242/dmm.013110
- The paper
- Suárez, J., Rivera, P., Arrabal, S., Crespillo, A., Serrano, A., Baixeras, E., Pavón, F. J., Cifuentes, M., Nogueiras, R., Ballesteros, J., Dieguez, C., & Rodríguez de Fonseca, F. (2013). Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.013110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.